Open-label Phase I Study for PEP or Treatment of HS-ARS PLX-R18 for the Post-Exposure Prevention (PEP) or Treatment of Hematopoietic Syndrome of Acute Radiation Syndrome (HS-ARS)

NCT03797040 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Ionizing Radiation Exposure

Interventions

BIOLOGICAL: Cell therapy

Sponsor

Pluristem Ltd.